Efficacy and safety of continuing sitagliptin when initiating insulin therapy in subjects with type 2 diabetes

被引：0
|
作者：
Roussel, R. [1 ]
Duran-Garcia, S. [2 ]
Zhang, Y. [3 ]
Shah, S. [3 ]
Darmiento, C. [3 ]
Shankar, R. R. [3 ]
O'Neill, E. A. [3 ]
Golm, G. T. [3 ]
Lam, R. L. H. [3 ]
Gantz, I. [3 ]
Kaufman, K. D. [3 ]
Engel, S. S. [3 ]
机构：
[1] Grp Hosp Bichat, Paris, France
[2] Valme Univ Hosp, Med Sch, Seville, Spain
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
    Sato, Seiji
    Saisho, Yoshifumi
    Kou, Kinsei
    Meguro, Shu
    Tanaka, Masami
    Irie, Junichiro
    Kawai, Toshihide
    Itoh, Hiroshi
    PLOS ONE, 2015, 10 (03):
  • [22] Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study
    Takai, Masahiko
    Ishikawa, Masashi
    Maeda, Hajime
    Kanamori, Akira
    Kubota, Akira
    Amemiya, Hikaru
    Iizuka, Takashi
    Iemitsu, Kotaro
    Iwasaki, Tomoyuki
    Uehara, Goro
    Umezawa, Shinichi
    Obana, Mitsuo
    Kaneshige, Hideaki
    Kaneshiro, Mizuki
    Kawata, Takehiro
    Sasai, Nobuo
    Saito, Tatsuya
    Takuma, Tetsuo
    Takeda, Hiroshi
    Tanaka, Keiji
    Tsurui, Nobuaki
    Nakajima, Shigeru
    Hoshino, Kazuhiko
    Honda, Shin
    Machimura, Hideo
    Matoba, Kiyokazu
    Minagawa, Fuyuki
    Minami, Nobuaki
    Miyairi, Yukiko
    Mokubo, Atsuko
    Motomiya, Tetsuya
    Waseda, Manabu
    Miyakawa, Masaaki
    Naka, Yoshikazu
    Terauchi, Yasuo
    Tanaka, Yasushi
    Matsuba, Ikuro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) : E30 - E33
  • [23] Impact of sitagliptin on hypoglyceamia in elderly subjects with type 2 diabetes treated with insulin
    Shankar, R. R.
    Long, J.
    Xu, L.
    O'Neill, E. A.
    Engel, S. S.
    DIABETOLOGIA, 2017, 60 : S358 - S358
  • [24] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [25] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
  • [26] ADMINISTRATIVE CLAIMS ANALYSIS OF PATIENTS WITH TYPE-2 DIABETES INITIATING SITAGLIPTIN THERAPY
    Fabunmi, R.
    Wade, R.
    Quimbo, R. A.
    Hou, L.
    Pawaskar, M. D.
    Misurski, D.
    VALUE IN HEALTH, 2009, 12 (03) : A98 - A98
  • [27] Type 2 diabetes mellitus - Guidelines for initiating insulin therapy
    Yeap, Bu Bang
    AUSTRALIAN FAMILY PHYSICIAN, 2007, 36 (07) : 549 - 553
  • [28] Invesitgation into the effects of initiating insulin therapy in type 2 diabetes
    Barratt, R
    Millward, J
    Truby, H
    Frost, G
    DIABETES, 2005, 54 : A166 - A166
  • [29] Initiating and intensifying insulin therapy in type 2 diabetes mellitus
    Tibaldi, Joseph
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (06): : 20 - 29
  • [30] Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes
    Yuan, Guoyue
    Jia, Jue
    Zhang, Caili
    Yu, Shuqin
    Dong, Sijing
    Ye, Jingjing
    Zhu, Tianyi
    Tang, Bingqian
    Qian, Weiyun
    Wang, Dong
    Yang, Ling
    Zhou, Libin
    Mao, Chaoming
    ENDOCRINE JOURNAL, 2014, 61 (05) : 513 - 521
12345